This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Charité – Universitätsmedizin Berlin, Fondation Bettencourt-Schueller, Université Pierre Et Marie Curie (Paris 6). Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 283 
1 out of 1 
1 out of 158 
Years Active: 2015
Title: Brigitte Autran: Innovator in Vaccination Technology
Introduction
Brigitte Autran is a prominent inventor based in Paris, France. She has made significant contributions to the field of vaccination, particularly through her innovative methods that enhance immune responses against pathogens.
Latest Patents
One of her notable patents is titled "Vaccination by Transcutaneous Targeting." This invention relates to a method of vaccination via hair follicles, allowing for the targeted delivery of vaccine components to antigen-presenting cells. This approach aims to induce a protective and effective immune response, showcasing her commitment to advancing medical technology.
Career Highlights
Brigitte has worked with esteemed organizations such as the Fondation Bettencourt-Schueller and Université Pierre et Marie Curie (Paris 6). Her work in these institutions has furthered research and development in the field of immunology and vaccination.
Collaborations
Throughout her career, Brigitte has collaborated with notable colleagues, including Behazine Combadiere and Annika Vogt. These partnerships have contributed to her innovative research and the successful implementation of her ideas.
Conclusion
Brigitte Autran's work in vaccination technology exemplifies her dedication to improving public health through innovative methods. Her contributions continue to influence the field and inspire future advancements in immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile